Aroa Biosurgery Ltd
ASX:ARX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aroa Biosurgery Ltd
ASX:ARX
|
NZ |
|
Faraday Copper Corp
TSX:FDY
|
CA |
|
Applied Therapeutics Inc
NASDAQ:APLT
|
US |
|
N
|
Northrop Grumman Corp
F:NTH
|
US |
|
Domacom Australia Ltd
ASX:DCL
|
AU |
|
Ellipsiz Ltd
SGX:BIX
|
SG |
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
IL |
|
Diversified Healthcare Trust
NASDAQ:DHC
|
US |
|
Salt Lake Potash Ltd
ASX:SO4
|
AU |
|
G
|
G Capital PCL
SET:GCAP
|
TH |
Wall Street
Price Targets
ARX Price Targets Summary
Aroa Biosurgery Ltd
According to Wall Street analysts, the average 1-year price target for
ARX
is 0.95 AUD
with a low forecast of 0.8 AUD and a high forecast of 1.22 AUD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ARX's stock price target?
Price Target
0.95
AUD
According to Wall Street analysts, the average 1-year price target for
ARX
is 0.95 AUD
with a low forecast of 0.8 AUD and a high forecast of 1.22 AUD.
What is Aroa Biosurgery Ltd's Revenue forecast?
Projected CAGR
16%
For the last 6 years the
compound annual growth rate for
Aroa Biosurgery Ltd's revenue is
24%.
The projected
CAGR
for the next 3 years is
16%.
